Cardioprotective effects of gallic acid in a rat ischemia-reperfusion model: role of apoptosis, inflammation, and antioxidant defense
Research in Pharmaceutical Sciences · 2026-01 · 21 (1) · 1-11
DOI: 10.4103/rps.rps_97_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Pharmaceutical Sciences, online erschienen am 26.12.2025. Verfasst von Afshin Nazari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khorramabad, I.R. Iran. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and purpose: Heart disease is a major global health problem. Gallic acid (GA) possesses cardioprotective properties. This study aimed to evaluate the therapeutic effects of GA pretreatment in ischemia-reperfusion (I/R) and elucidate its underlying mechanisms. Experimental approach: Forty adult male Wistar rats were subjected to this experiment. GA was given to the rats through gavage at doses of 15 and 30 mg/kg/day, 10 days before the induction of ischemia. To induce I/R, the left anterior descending coronary artery was occluded for 30 min, and reperfusion continued for 24 h. Malondialdehyde (MDA) levels, antioxidant enzyme activity, and inflammatory cytokines were assessed using kits. Myocardial injury markers were analyzed by ELISA, and infarct size was assessed through 2,3,5-triphenyltetrazolium chloride staining. Real-time polymerase chain reaction was utilized to quantify the relative gene expression of Bax and Bcl-2 . Findings/Results: The findings indicated that pretreatment with GA led to significant improvement in inflammatory cytokines, antioxidant enzyme activity, and a decrease in MDA levels. GA also decreased infarct size and myocardial injury markers significantly. Moreover, pretreatment with GA revealed a significant increase in the expression of the Bcl-2 gene, while the expression of the Bax gene decreased. Conclusion and implications: Inclusively, the results suggested that GA may hold significant potential as a therapeutic agent for reducing myocardial injury in the context of I/R, with 30 mg/kg/day proving more effective than 15 mg/kg/day, offering a promising path for further investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khorramabad, I.R. Iran.
- Department of Physiology and Pharmacology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, I.R. Iran.
- Department of Anesthesiology, School of Medicine, Besat Hospital, Hamadan University of Medical Sciences, Hamadan, I.R. Iran.
Zitieren
APA
Nazari, A., Souri, F., Ghoranzadeh, V., Sedighi, M., Shoorabeh, F. F., & Kalansara, N. K. (2026). Cardioprotective effects of gallic acid in a rat ischemia-reperfusion model: role of apoptosis, inflammation, and antioxidant defense. Research in Pharmaceutical Sciences, 21(1), 1-11. https://doi.org/10.4103/rps.rps_97_25
Vancouver
Nazari A, Souri F, Ghoranzadeh V, Sedighi M, Shoorabeh FF, Kalansara NK. Cardioprotective effects of gallic acid in a rat ischemia-reperfusion model: role of apoptosis, inflammation, and antioxidant defense. Research in Pharmaceutical Sciences. 2026;21(1):1-11. doi:10.4103/rps.rps_97_25
BibTeX
@article{Nazari2026,
author = {Nazari, Afshin and Souri, Faraz and Ghoranzadeh, Vajihe and Sedighi, Mehrnoosh and Shoorabeh, Fazlollah Fathollahi and Kalansara, Narges Khojasteh},
title = {Cardioprotective effects of gallic acid in a rat ischemia-reperfusion model: role of apoptosis, inflammation, and antioxidant defense},
journal = {Research in Pharmaceutical Sciences},
year = {2026},
volume = {21},
number = {1},
pages = {1--11},
doi = {10.4103/rps.rps_97_25}
}
EUVIMED